Skip to main content
Clinical Trials/JPRN-UMIN000006429
JPRN-UMIN000006429
Completed
Phase 4

Study the efficacy and safety of fentanyl patches on QOL/ADL in patients with chronic pain - Study of efficacy and safety of fentanyl patches for chronic pain.

Kawasaki Medical School,Department of Orthopedics, Traumatology and Spine Surgery0 sites5 target enrollmentDecember 1, 2011

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
patients with chronic pain
Sponsor
Kawasaki Medical School,Department of Orthopedics, Traumatology and Spine Surgery
Enrollment
5
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2011
End Date
December 31, 2013
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kawasaki Medical School,Department of Orthopedics, Traumatology and Spine Surgery

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with hypersensitivity to opioids Patients with a history of opioid abuse Patients with respiratory dysfunction such as chronic lung disease Patients with asthma Patients with severe cardiac dysfunction Patients with severe liver and renal dysfunction Intracranial hypertension, patients with impaired consciousness Eczema at the site of drug patch testing, patients with atopic dermatitis, etc. Patients with fever above 40 degree was observed Pregnant women, patients might have been pregnant or nursing mothers Within two days before starting the test, patients who are scheduled to be administered to patients receiving an opioid receptor antagonist such as pentazocine or buprenorphine.

Outcomes

Primary Outcomes

Not specified

Similar Trials